We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Biomedica Plc | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
8.50 | 3.86% | 228.50 | 228.50 | 231.00 | 234.00 | 221.00 | 222.00 | 323,586 | 16:35:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medicinal Chems,botanicl Pds | 139.99M | -45.16M | -0.4676 | -4.90 | 221.17M |
TIDMOXB
RNS Number : 8619P
Oxford Biomedica PLC
05 September 2017
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
1 Issuer Oxford BioMedica PLC ------ ------------------------ ----------------------------------- 2 Reason for notification Notification relates to DTR 3.1.2R ------ ------------------------ ----------------------------------- 3 Name of PDMR Martin Diggle ------ ------------------------ ----------------------------------- 4 Connected person Notification relates to following connected persons: Vulpes Testudo Fund ------ ------------------------ ----------------------------------- 5 Notification Notification in respect of in respect of holdings of persons in 4 above ------ ------------------------ ----------------------------------- 6 Description Oxford BioMedica PLC ordinary of shares shares of 1p each ------ ------------------------ ----------------------------------- 7 Name of registered Vulpes Life Sciences Fund shareholders - 549,932,000 shares and number of Vulpes Testudo Fund - 30,956,834 shares shares ------ ------------------------ ----------------------------------- 8 Nature of transaction Acquisition and Disposal ------ ------------------------ ----------------------------------- 9 Number of shares Vulpes Testudo Fund - 320,000 acquired shares ------ ------------------------ ----------------------------------- 10 Percentage of Vulpes Testudo Fund- 0.01% issued class acquired ------ ------------------------ ----------------------------------- 11 Shares disposed Vulpes Testudo Fund - 300,000 ------ ------------------------ ----------------------------------- 12 Percentage of Vulpes Testudo Fund - 0.01% issued class disposed ------ ------------------------ ----------------------------------- 13/14 Price per share Vulpes Testudo Fund of transactions, Sold 300,000 shares @ GBP0.097, and date 01 Sep 2017 Bought 320,000 shares @ GBP0.094, 01 Sep 2017 ------ ------------------------ ----------------------------------- 15 Total holding Vulpes Life Sciences Fund following notification - 549,932,000 shares and total percentage 17.7% holding following Vulpes Testudo Fund - 30,976,434 notification shares 1.0% ------ ------------------------ ----------------------------------- 16 Date issuer 05 Sep 2017 informed ------ ------------------------ ----------------------------------- 23 Any additional None information ------ ------------------------ ----------------------------------- 24 Contact name S. Paynter, Chief Financial and telephone Officer number Oxford BioMedica +44 (0)1865 783000 ------ ------------------------ -----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBGGDCRXGBGRU
(END) Dow Jones Newswires
September 05, 2017 06:39 ET (10:39 GMT)
1 Year Oxford Biomedica Chart |
1 Month Oxford Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions